IMB-150

N/A

Report date: 2025/10/27 17:54:59

Base Information

Drug NameIMB-150
Drug Alias NameA novel formulation of lidocaine (Imbrium Therapeutics)IMB-9011500IMB-150LYT-503ALV-107 +[6
ClassificationSmall molecules
Mechanisms of ActionSodium channel alpha subunit modulators
TargetsSodium channel alpha subunit
Therapy Area/IndicationsCystitis, Interstitial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlivio Therapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesAlivio Therapeutics Inc
Active IndicationsCystitis, Interstitial
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A